This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cappelletty, D. M.
Right arrow Articles by Rybak, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cappelletty, D. M.
Right arrow Articles by Rybak, M. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 03 1996, 677-683, Vol 40, No. 3
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa

DM Cappelletty and MJ Rybak
Department of Pharmacy Services, Detroit Receiving Hospital/University Health Center, Michigan 48201, USA.

The purpose of this study was to determine if synergism was maintained for various combinations of beta-lactams with an aminoglycoside against four clinical strains and one laboratory strain of Pseudomonas aeruginosa which were resistant, according to the MICs, to the beta- lactams and/or aminoglycoside. The results from both the checkerboard and killing curve methodologies were compared. The laboratory strain (ATCC 27853) was manipulated in vitro by serial passage onto agar containing increasing concentrations of each antibiotic to select for resistance. One clinical isolate (R61) was also serially passed to raise the MIC of piperacillin from 128 to 1,024 micrograms/ml. The fractional inhibitory concentration indices for all isolates indicated indifference for all combination therapies, with values ranging from 0.6 to 3. In contrast, killing curve results for all isolates demonstrated synergism with drug concentrations at either one-fourth or one-half the MIC for each organism. The MIC of piperacillin for the laboratory-manipulated clinical isolate R61 was 1,024 micrograms/ml, and synergism was still observed with concentrations of one-half the MIC of piperacillin and amikacin. For clinical isolate R166, which was beta-lactam and tobramycin resistant, synergism continued to be demonstrated with concentrations of tobramycin (1/16 MIC) in combination with piperacillin and cefepime at 1/2 the MIC. The results of this study indicate that against P. aeruginosa, synergism is observed in spite of resistance to beta-lactams and/or aminoglycosides. Synergism appears to be maintained even at very high MICs (piperacillin, 1,024 micrograms/ml; tobramycin, 128 micrograms/ml) with drug concentrations within achievable therapeutic ranges. With current definitions of synergism there was a complete lack of correlation between the results obtained by the checkerboard and killing curve methodologies, with the fractional inhibitory concentration indices showing indifference and killing curves resulting in synergism. The methodologies and definitions of synergism or antagonism are variable and not standardized and should be reevaluated.


This article has been cited by other articles:

  • Foweraker, J. E., Laughton, C. R., Brown, D. F., Bilton, D. (2009). Comparison of Methods To Test Antibiotic Combinations against Heterogeneous Populations of Multiresistant Pseudomonas aeruginosa from Patients with Acute Infective Exacerbations in Cystic Fibrosis. Antimicrob. Agents Chemother. 53: 4809-4815 [Abstract] [Full Text]  
  • Foweraker, J. (2009). Recent advances in the microbiology of respiratory tract infection in cystic fibrosis. Br Med Bull 89: 93-110 [Abstract] [Full Text]  
  • Credito, K., Lin, G., Koeth, L., Sturgess, M. A., Appelbaum, P. C. (2009). Activity of Levofloxacin Alone and in Combination with a DnaK Inhibitor against Gram-Negative Rods, Including Levofloxacin-Resistant Strains. Antimicrob. Agents Chemother. 53: 814-817 [Abstract] [Full Text]  
  • Lim, T.-P., Ledesma, K. R., Chang, K.-T., Hou, J.-G., Kwa, A. L., Nikolaou, M., Quinn, J. P., Prince, R. A., Tam, V. H. (2008). Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug-Resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 52: 2898-2904 [Abstract] [Full Text]  
  • Pankuch, G. A., Lin, G., Seifert, H., Appelbaum, P. C. (2008). Activity of Meropenem with and without Ciprofloxacin and Colistin against Pseudomonas aeruginosa and Acinetobacter baumannii. Antimicrob. Agents Chemother. 52: 333-336 [Abstract] [Full Text]  
  • Petersen, P. J., Labthavikul, P., Jones, C. H., Bradford, P. A. (2006). In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother 57: 573-576 [Abstract] [Full Text]  
  • Pankey, G. A., Ashcraft, D. S. (2005). In Vitro Synergy of Ciprofloxacin and Gatifloxacin against Ciprofloxacin-Resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49: 2959-2964 [Abstract] [Full Text]  
  • Foweraker, J. E., Laughton, C. R., Brown, D. F. J., Bilton, D. (2005). Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. J Antimicrob Chemother 55: 921-927 [Abstract] [Full Text]  
  • Tam, V. H., Schilling, A. N., Lewis, R. E., Melnick, D. A., Boucher, A. N. (2004). Novel Approach to Characterization of Combined Pharmacodynamic Effects of Antimicrobial Agents. Antimicrob. Agents Chemother. 48: 4315-4321 [Abstract] [Full Text]  
  • Pag, U., Oedenkoven, M., Papo, N., Oren, Z., Shai, Y., Sahl, H.-G. (2004). In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates. J Antimicrob Chemother 53: 230-239 [Abstract] [Full Text]  
  • Sweeney, M. T., Zurenko, G. E. (2003). In Vitro Activities of Linezolid Combined with Other Antimicrobial Agents against Staphylococci, Enterococci, Pneumococci, and Selected Gram-Negative Organisms. Antimicrob. Agents Chemother. 47: 1902-1906 [Abstract] [Full Text]  
  • Fish, D. N., Choi, M. K., Jung, R. (2002). Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs. J Antimicrob Chemother 50: 1045-1049 [Abstract] [Full Text]  
  • Desbiolles, N., Piroth, L., Lequeu, C., Neuwirth, C., Portier, H., Chavanet, P. (2001). Fractional Maximal Effect Method for In Vitro Synergy between Amoxicillin and Ceftriaxone and between Vancomycin and Ceftriaxone against Enterococcus faecalis and Penicillin-Resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45: 3328-3333 [Abstract] [Full Text]  
  • Ednie, L. M., Credito, K. L., Khantipong, M., Jacobs, M. R., Appelbaum, P. C. (2000). Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods. J Antimicrob Chemother 45: 633-638 [Abstract] [Full Text]  
  • Bonacorsi, S., Fitoussi, F., Lhopital, S., Bingen, E. (1999). Comparative In Vitro Activities of Meropenem, Imipenem, Temocillin, Piperacillin, and Ceftazidime in Combination with Tobramycin, Rifampin, or Ciprofloxacin against Burkholderia cepacia Isolates from Patients with Cystic Fibrosis. Antimicrob. Agents Chemother. 43: 213-217 [Abstract] [Full Text]  
  • Visalli, M. A., Jacobs, M. R., Appelbaum, P. C. (1998). Determination of Activities of Levofloxacin, Alone and Combined with Gentamicin, Ceftazidime, Cefpirome, and Meropenem, against 124 Strains of Pseudomonas aeruginosa by Checkerboard and Time-Kill Methodology. Antimicrob. Agents Chemother. 42: 953-955 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»